A SARS-CoV-2 Outbreak Among Nursing Home Residents Vaccinated with a Booster Dose of mRNA COVID-19 Vaccine.


Journal

Journal of community health
ISSN: 1573-3610
Titre abrégé: J Community Health
Pays: Netherlands
ID NLM: 7600747

Informations de publication

Date de publication:
08 2022
Historique:
accepted: 28 02 2022
pubmed: 26 3 2022
medline: 20 7 2022
entrez: 25 3 2022
Statut: ppublish

Résumé

This study describes a SARS-CoV-2 outbreak caused by the Delta (B.1.617.2) variant in a nursing home in Central Italy during October-November 2021. Trained interviewers collected data from residents, staff, and administration officers with an agreed informed consent procedure. Thirty-two (44.5%) out of 72 residents (median age 89 years) and six (26.1%) of 23 healthcare workers were found to be infected with SARS-CoV-2. Infections occurred more often among residents with a higher index of independence in daily living activities, suggesting an increased risk for those with more interactions. Twenty-five infected residents (78.1%) received the booster dose of mRNA anti-COVID-19 vaccine > 7 days before SARS-CoV-2 onset. Half of the infected residents had mild symptoms, and only three required hospitalisation, one of whom died from COVID-19 complications. The study underlines the effectiveness of a booster dose in providing a high protection against severe disease and hospitalisation even among vulnerable individuals infected with the Delta variant of concern.

Identifiants

pubmed: 35334031
doi: 10.1007/s10900-022-01082-8
pii: 10.1007/s10900-022-01082-8
pmc: PMC8949830
doi:

Substances chimiques

COVID-19 Vaccines 0
RNA, Messenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

598-603

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145
pubmed: 35085224
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Lancet. 2021 Dec 4;398(10316):2093-2100
pubmed: 34756184
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):118-124
pubmed: 35085218
J Community Health. 2022 Apr;47(2):211-225
pubmed: 34628568
Front Med (Lausanne). 2021 Jun 04;8:617264
pubmed: 34150789
J Infect Dis. 2022 Mar 2;225(5):785-792
pubmed: 34850049
N Engl J Med. 2021 Oct 7;385(15):1393-1400
pubmed: 34525275
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
Euro Surveill. 2021 Dec;26(48):
pubmed: 34857068
Nat Med. 2021 Dec;27(12):2127-2135
pubmed: 34650248
J Am Geriatr Soc. 2020 Oct;68(10):2153-2162
pubmed: 32735036

Auteurs

Giancarlo Ripabelli (G)

Department of Medicine and Health Sciences "Vincenzo Tiberio", University of Molise, Campobasso, Italy. ripab@unimol.it.
School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy. ripab@unimol.it.

Michela Lucia Sammarco (ML)

Department of Medicine and Health Sciences "Vincenzo Tiberio", University of Molise, Campobasso, Italy.

Giovanni Rezza (G)

Head Prevention Directorate, Ministry of Health, Rome, Italy.

Antonio D'Amico (A)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Roberta De Dona (R)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Mariagrazia Iafigliola (M)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Albino Parente (A)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Nicandro Samprati (N)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Arturo Santagata (A)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Carmen Adesso (C)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Anna Natale (A)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Michela Anna Di Palma (MA)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Fabio Cannizzaro (F)

School of Specialization in Hygiene and Preventive Medicine, University of Molise, Campobasso, Italy.

Cosimo Dentizzi (C)

"Don Carlo Pistilli" Nursing Home, Campobasso, Italy.

Paola Stefanelli (P)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Manuela Tamburro (M)

Department of Medicine and Health Sciences "Vincenzo Tiberio", University of Molise, Campobasso, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH